Walvax BioTech (300142) — Capital Reinvestment Ratio
Walvax BioTech (300142) has a Capital Reinvestment Ratio of 0.26x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥278.33 Million) in capital expenditures (CN¥71.03 Million). Check 300142 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Walvax BioTech Capital Reinvestment Ratio (2007–2025)
This chart tracks Walvax BioTech's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see 300142 cash generation efficiency.
Annual Capital Reinvestment Ratio for Walvax BioTech (2007–2025)
Year-by-year Capital Reinvestment Ratio for Walvax BioTech from 2007 to 2025. See free cash flow generation of Walvax BioTech to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.03x | CN¥494.37 Million | CN¥509.54 Million | ▲ +94.2% |
| 2024 | 0.53x | CN¥1.04 Billion | CN¥550.03 Million | ▼ -36.4% |
| 2023 | 0.83x | CN¥1.13 Billion | CN¥945.52 Million | ▼ -8.2% |
| 2022 | 0.91x | CN¥1.20 Billion | CN¥1.09 Billion | ▼ -42.0% |
| 2021 | 1.56x | CN¥705.28 Million | CN¥1.10 Billion | ▼ -56.1% |
| 2020 | 3.57x | CN¥114.19 Million | CN¥407.13 Million | ▼ -37.2% |
| 2019 | 5.67x | CN¥62.02 Million | CN¥351.82 Million | ▲ +24.9% |
| 2012 | 4.54x | CN¥78.38 Million | CN¥355.87 Million | ▲ +111.4% |
| 2011 | 2.15x | CN¥91.98 Million | CN¥197.56 Million | ▲ +13.0% |
| 2010 | 1.90x | CN¥86.71 Million | CN¥164.81 Million | ▲ +109.0% |
| 2009 | 0.91x | CN¥82.18 Million | CN¥74.75 Million | ▲ +58.7% |
| 2007 | 0.57x | CN¥31.85 Million | CN¥18.26 Million | — |